Adicet Bio

formerly Adicet

Gamma Delta T cells | Off the-shelf T cell therapy

Redwood City, United States · Founded 2014 · $211.0M raised

Employees
51–200
Founded
2014
Business Model
B2B
Total Funding
$211.0M
Last Round
$80.0M Venture RoundOct 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Adicet Bio is a clinical-stage biotechnology company developing allogeneic gamma delta T-cell therapies. Its programs are designed as off-the-shelf cell therapies for patients with autoimmune diseases and cancer. The company focuses on discovering and advancing gamma delta CAR T-cell candidates intended to deliver new treatment options in these therapeutic areas.

Summary

Adicet Bio is a Biotech company based in Redwood City, United States, founded in 2014. It has raised $211.0M in total across 3 rounds, most recently a $80.0M Venture Round in Oct 2025. Investors include OrbiMed, Novartis Venture Fund and Pontifax.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundRegistered Direct OfferingOct 2025
$80.0M

Sign up to see all 3 events

Funding: Series A through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Adicet Bio on Indexed.vc
<a href="https://indexed.vc/companies/adicet-bio"><img src="https://indexed.vc/api/badge/company/adicet-bio" alt="Adicet Bio on Indexed.vc" width="260" height="76" /></a>